Bhanutej Mallangi - Goldstone Technologies Head Product
| GOLDTECH | 48.13 7.28 13.14% |
Executive
Bhanutej Mallangi is Head Product of Goldstone Technologies Limited
| Address | My Home Hub, Block No. I, Hyderabad, India, 500081 |
| Phone | 91 40 6628 4999 |
| Web | https://www.aiontech.ai |
Goldstone Technologies Management Efficiency
The company has return on total asset (ROA) of (0.0325) % which means that it has lost $0.0325 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1094 %, meaning that it generated $0.1094 on every $100 dollars invested by stockholders. Goldstone Technologies' management efficiency ratios could be used to measure how well Goldstone Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At present, Goldstone Technologies' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Himanshu Ranvah | JB Chemicals Pharmaceuticals | 40 | |
| Sridhar Bharadwaj | JB Chemicals Pharmaceuticals | 58 | |
| Yogesh Gupta | Global Health Limited | 50 | |
| Ajey Maharaj | Fortis Healthcare Limited | N/A | |
| Niralkumar Zota | Zota Health Care | 47 | |
| Anil Vinayak | Fortis Healthcare Limited | 58 | |
| Bipin Kumar | Fortis Healthcare Limited | N/A | |
| Rahul Ranjan | Global Health Limited | 45 | |
| Sanjay Sinha | Fortis Healthcare Limited | N/A | |
| Suresh Bhise | JB Chemicals Pharmaceuticals | 59 | |
| Viral Mandviwala | Zota Health Care | 49 | |
| Ruben Parma | Zota Health Care | N/A | |
| Sandeep Phadnis | JB Chemicals Pharmaceuticals | 56 | |
| Narayan Saraf | JB Chemicals Pharmaceuticals | 45 | |
| Milind Joshi | JB Chemicals Pharmaceuticals | 60 | |
| Vivek Goyal | Fortis Healthcare Limited | N/A | |
| Jason DSouza | JB Chemicals Pharmaceuticals | N/A | |
| Ashvin Variya | Zota Health Care | 33 | |
| Ravi Babu | Krebs Biochemicals and | N/A | |
| Bhagwat Deora | JB Chemicals Pharmaceuticals | 43 | |
| Richa Singh | Global Health Limited | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | -0.0325 |
Goldstone Technologies Leadership Team
Elected by the shareholders, the Goldstone Technologies' board of directors comprises two types of representatives: Goldstone Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goldstone. The board's role is to monitor Goldstone Technologies' management team and ensure that shareholders' interests are well served. Goldstone Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goldstone Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Niralee Kotdawala, Company Officer | ||
| Jagrit Gandotra, Chief Officer | ||
| Pavan Chavali, MD Director | ||
| Murali Veerisetty, Senior Sales | ||
| Adalat Srikanth, Company Officer | ||
| Vithal Popuri, Chief Officer | ||
| Seetepalli Raghunand, Executive Director | ||
| Rahul Mallampati, Senior Sales | ||
| Afroze Banu, Director Resources | ||
| Vijay VS, Chief Officer | ||
| Bhanutej Mallangi, Head Product |
Goldstone Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Goldstone Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | -0.0325 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 1.66 B | ||||
| Shares Outstanding | 34.58 M | ||||
| Shares Owned By Insiders | 62.75 % | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 2.29 X | ||||
| Revenue | 932.76 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Goldstone Stock
Goldstone Technologies financial ratios help investors to determine whether Goldstone Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldstone with respect to the benefits of owning Goldstone Technologies security.